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Structure and expression of two nuclear receptor
genes in marsupials: insights into the evolution
of the antisense overlap between the a-thyroid
hormone receptor and Rev-erba
Brandon C Rindfleisch1,2†, M Scott Brown1,3†, John L VandeBerg4, Stephen H Munroe1*
Abstract
Background: Alternative processing of a-thyroid hormone receptor (TRa, NR1A1) mRNAs gives rise to two
functionally antagonistic nuclear receptors: TRa1, the a-type receptor, and TRa2, a non-hormone binding variant
that is found only in mammals. TRa2 shares an unusual antisense coding overlap with mRNA for Rev-erba
(NR1D1), another nuclear receptor protein. In this study we examine the structure and expression of these genes in
the gray short-tailed opossum, Monodelphis domestica, in comparison with that of eutherian mammals and three
other marsupial species, Didelphis virginiana, Potorous tridactylus and Macropus eugenii, in order to understand the
evolution and regulatory role of this antisense overlap.
Results: The sequence, expression and genomic organization of mRNAs encoding TRa1 and Rev-erba are very
similar in the opossum and eutherian mammals. However, the sequence corresponding to the TRa2 coding region
appears truncated by almost 100 amino acids. While expression of TRa1 and Rev-erba was readily detected in all
tissues of M. domestica ages 0 days to 18 weeks, TRa2 mRNA was not detected in any tissue or stage examined.
These results contrast with the widespread and abundant expression of TRa2 in rodents and other eutherian
mammals. To examine requirements for alternative splicing of TRa mRNAs, a series of chimeric minigenes was
constructed. Results show that the opossum TRa2-specific 5’ splice site sequence is fully competent for splicing
but the sequence homologous to the TRa2 3’ splice site is not, even though the marsupial sequences are
remarkably similar to core splice site elements in rat.
Conclusions: Our results strongly suggest that the variant nuclear receptor isoform, TRa2, is not expressed in
marsupials and that the antisense overlap between TRa and Rev-erba thus is unique to eutherian mammals.
Further investigation of the TRa and Rev-erba genes in marsupial and eutherian species promises to yield
additional insight into the physiological function of TRa2 and the role of the associated antisense overlap with
Rev-erba in regulating expression of these genes.
Background
Recent genome-wide studies have revealed far more
extensive transcription of mammalian genomes than
previously recognized [1-6]. One consequence of this
pervasive transcription is the occurrence of widespread
bidirectional transcription that results in overlapping
transcripts antisense to most known mRNAs [5,7-9].
Such antisense transcription takes several forms. Both
long and short non-coding antisense transcripts have
been described overlapping either the 5’ or 3’ ends of
mRNAs. In other instances two mRNAs encoded on
opposite strands share such an overlap. Although regu-
latory implications of antisense transcription are unclear,
many studies suggest that the mechanisms associated
with expression of antisense RNA in eukaryotes are
remarkably diverse and mechanistically complex [9-14].
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One of the first examples of an antisense overlap
between two mRNAs involves two nuclear receptor
genes, the a-type thyroid hormone receptor gene (TRa;
also NR1A1 or THRA) and the Rev-erba gene (NR1D1)
[15-17]. These genes share an antisense overlap that
reflects the presence of a novel alternatively spliced
mRNA that is highly conserved in most mammals but is
absent in non-mammalian vertebrates [18]. Alternative
processing of TRa pre-mRNAs yields two functionally
distinct proteins. One is the canonical thyroid hormone
(T3) receptor, TRa1, that activates target genes in a
thyroid hormone (T3)-dependent manner. The other,
TRa2, has a novel C-terminal sequence encoded by an
exon antisense to Rev-erba. TRa2 mRNA lacks both
the hormone-binding domain and a critical activation
domain present in TRa1 and may function as a weak
dominant negative repressor, repressing expression of
genes activated by TRa1 in the presence of T3 [17].
Rev-erba has a DNA-binding specificity distinct from
TRa1 and TRa2. Like TRa1, Rev-erba possesses a
canonical ligand binding domain but, like TRa2, it lacks
the AF-2 activation domain. Thus, both Rev-erba and
TRa2 are constitutive repressors, although they bind
distinct sets of target genes.
TRa1 and Rev-erba play important roles in metabolic
and developmental regulation [19-21]. TRa1 mediates
T3 activity critical for vertebrate development and
homeostatic metabolism. Rev-erba plays critical roles in
adipogenesis and lipid metabolism, while occupying a
specific node in the mammalian circadian clock [22-26].
While previously considered a ligandless orphan recep-
tor, Rev-erba has recently been shown to bind heme
specifically within its canonical ligand binding domain
(LBD) [24,26]. Interactions of Rev-erba with its co-
repressors are enhanced in the presence of heme and,
with heme bound, may respond to physiological regula-
tors such as nitric oxide [23,27,28]. Thus, Rev-erba has
emerged as an important integrator of inputs from mul-
tiple physiologic pathways [29-31].
The overlap architecture of the region encoding TRa
and Rev-erba (here referred to as the TRa/Rev-erba
locus) and the physiological importance of these nuclear
receptors raise important questions relating to the func-
tion, evolution and regulation of this locus. The evolu-
tionary constraints imposed on such a bidirectional
coding sequence argue that it is highly unlikely that
such an overlap would occur without some functional
benefit. Several lines of evidence support the hypothesis
that expression of Rev-erba mRNA may affect the bal-
ance between TRa1 and TRa2 through inhibition of
TRa2 splicing [32-35]; however, such an interaction has
not been demonstrated under physiological conditions.
In this study we first analyze the structure of the
TRa/Rev-erba locus in Monodelphis domestica, the gray
short-tailed opossum, the first published marsupial gen-
ome [36], and compare it with that of other marsupials.
Individually, TRa and Rev-erba genes and transcripts
are highly conserved in the opossum in comparison
with those of eutherian mammals. However, the region
corresponding to the Rev-erba/TRa2 overlap in euther-
ian mammals displays several divergent features. Most
of the C-terminal coding sequence unique to TRa2 is
missing in M. domestica due to the introduction of an
in-frame stop codon that eliminates the bidirectional
coding overlap with Rev-erba. Furthermore, expression
of TRa2 mRNA was not detected in the opossum in
any of a variety of tissues or developmental stages.
These results are surprising given the remarkable
conservation of TRa2 and its abundant and develop-
mentally regulated expression in eutherian mammals.
Analysis of chimeric minigenes comprised of opossum
and rat sequences demonstrated that opossum
sequences homologous to the TRa2-specific splice site
(3’ss) are very poorly utilized in comparison with similar
rat minigenes. These studies thus document the evolu-
tion of a novel alternatively spliced exon in mammals
and the creation of antisense overlap between two
important regulatory proteins.
Results
Structures of eutherian TRa1 and Rev-erba mRNAs are
conserved in marsupials
Inspection of the genome of Monodelphis domestica [36]
reveals a single locus on chromosome 2 in which the
TRa and Rev-erba genes are arrayed in a convergent
orientation similar to that in rat and other mammalian
genomes (Figure 1). The coding regions for TRa1 (addi-
tional file 1 Panel A) and Rev-erba are separated by
only 3.85 kb, similar to the close spacing of the coding
regions in the rat genome (3.71 kb). Furthermore, the
non-coding sequence extending across and between the
3’ ends of these genes is also very well conserved (Figure
1B). The most striking conservation is located at the
extreme 3’ end of TRa1 mRNA, in which a sequence of
140 bp is almost identical to that in the rat and other
eutherian mammals. The region surrounding the 3’ end
of Rev-erba is also highly conserved and is flanked
upstream and downstream by homopolymeric runs of 3
or more C (C-rich or Cn) and G (G-rich or Gn) residues,
respectively, as is the case in other mammals (Figure 1B
and additional file 2).
Closer inspection of the sequence for M. domestica
TRa, however, reveals that the first coding exon of
TRa1 mRNA is entirely missing in the genome assem-
bly due to a 5 kb gap [36]. Also, apparent sequencing
errors at positions 54 and 124 of exon 6 disrupt the
reading frame for TRa1 by introducing, respectively, a
one-base insertion and a stop codon. The complete
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coding sequence for M. domestica TRa1 was obtained
by sequencing cDNA using primers complementary to
conserved sequences in the 5’ UTR and at intervals
throughout the coding sequence. The TRa1 coding
sequence for M. domestica from this analysis was identi-
cal in all other respects to the current genome assembly
(additional file 1 Panel A). As shown in Figure 1 the
amino acid sequence of opossum TRa1 is closely similar
to that of rat, with 93% identity at the amino acid level.
Rev-erba is also well conserved with 84% identity. The
3’ ends of TRa1 and Rev-erba mRNAs from opossum
were mapped via RNase protection assays and 3’ RACE,
respectively (results not shown), and were found to
coincide precisely with the sites previously reported for
rat [15,32] as indicated in additional file 2. To confirm
these observations, mRNA sequences for TRa1 and
Rev-erba were determined for a second marsupial,
Potorous tridactylus (the long-nosed potoroo). The
opossum and potoroo amino acid sequences, represent-
ing the two largest marsupial orders, Didelphia and
Diprotodontia, about 80 My diverged [37], are very simi-
lar: 99% and 96% identity for TRa1 and Rev-erba,
respectively (additional file 1).
In contrast to the strong conservation of TRa1 and
Rev-erba, sequences corresponding to the alternatively
spliced exon 10 of TRa2 mRNA display a puzzling mix
of conserved and non-conserved features. Sequences cor-
responding to the core 3’ss elements for this exon are
nearly identical in rat and M. domestica, including the
intronic polypyrimidine tract and the non-consensus
AAG immediately preceding the 3’ss (Figure 2B and
additional file 2). Sequence at the 5’ end of exon 10, cor-
responding to 11 codons in rat TRa2, is also well con-
served but at that point the similarity between marsupial
and eutherian sequence ends abruptly until reaching the
coding sequence for Rev-erba. The divergent region
includes a 12 nucleotide insertion in opossum and an in-
frame stop codon immediately preceding the stop codon
for Rev-erba on the strand antisense to TRa. These adja-
cent stop codons, present in both species of opossum but
absent in wallaby and potoroo, as described below, pre-
cisely eliminate the bidirectional coding overlap between
TRa2 and Rev-erba mRNAs seen in rat and other
eutherian mammals [17,38]. Finally, the Rev-erba amino
acid sequence encoded by its terminal exon is identical in
opossum and rat. However, there are 26 synonymous
substitutions in Rev-erba sequence, almost all of which
alter the coding potential of the TRa strand in opossum.
To further explore the significance of this sequence
comparison, we examined 1.5 kb of genomic sequence
that span the 3’ end of TRa1 and extend across exon 8
and part of exon 7 of Rev-erba in three other marsupial
species: Didelphis virginiana (the Virginia opossum),
P. tridactylus, and Macropus eugenii (the tammar wal-
laby). Alignment of all four marsupial sequences with
those of rat shows a high level of conservation of marsu-
pial features similar to that shown in Figure 1B and
additional file 2. As expected, since both are of the
order Didelphimorphia, the sequence of the opossum D.
virginiana is very similar to that of M. domestica (89%
identity across mostly non-coding sequence). Both
include a 12-nucleotide insertion and in-frame stop
codon in the region adjacent to the stop codon for Rev-
erba (Figure 2B). Sequences for wallaby and potoroo
(both of the order Diprotodontia) are similar to those
from the opossums in the region homologous to exon
10 of TRa2. Furthermore, the amino acid sequences
encoded by the 3’ exon of Rev-erba in all four marsu-
pials are identical to that of rat except for a single
residue change in the potoroo, although each sequence
contains many substitutions which are silent with
respect to Rev-erba (Figure 2C).
Despite their high degree of similarity overall, the
potoroo and wallaby sequences differ from those of the
TRα
Rev-erbα
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TRα1     Cn       Rev   Gn   TRα2      exon-exon           Rev                     Rev3’UTR              pA             3’ss         overlap            intron 7           exon 7
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Figure 1 The TRa/Rev-erba locus is conserved in marsupials.
A. Structure of TRa and Rev-erba genes is shown schematically for
rat and M. domestica. Rectangular boxes indicate exons, boxes
terminating in arrows represent poly(A) sites, dark shading indicates
coding sequences and bold vertical lines the alternative 5’ss splice
site for exon 9A and stop codons for TRa1 (exon 9) and TRa2 (exon
10). Alternative splicing of TRa2 (exon 9A to exon 10) is indicated
by dotted angle line. Percent amino acid identity is indicated above
each exon and exon numbering is shown in bold below.
Conservation of TRa2 exon 10 is described in Figure 2. Probes for
RNase protection assays are indicated by bold lines under TRa exon
9A and Rev-erba exon 6. Hatched ellipses indicate positions of
elements that enhance TRa2 mRNA splicing [38]. B. (top) To-scale
enlargement of the antisense overlap showing portions of exons
from TRa1, TRa2 and Rev-erba mRNAs within shaded region in
panel A. Shaded horizontal bar indicates eight subregions based on
an alignment of eutherian and marsupial sequences across this
region (additional file 2). Cn and Gn represent regions that include
multiple runs of C and G residues, respectively. Rev pA is the
conserved region centered on the Rev-erba poly(A) site. Table at
bottom shows percent identity for selected pairwise comparsions:
SAO, South American opossum (M. domestica); NAO, North
American opossum (D. viriginiana); potoroo, P. tridactylus. Asterisks
indicate highly gapped regions in the alignment.
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opossums in one notable respect: there is a two-basepair
deletion immediately downstream of sequences homolo-
gous to the 3’ss of exon 10 in TRa2 mRNA. This dele-
tion disrupts the reading frame corresponding to the
C-terminus of TRa2 and creates a novel open reading
frame that extends past the Rev-erba stop codon, over-
lapping the Rev-erba coding region by 16 codons
(Figure 2B and 2C).
Expression of TRa and Rev-erba mRNAs in marsupials
Given the conservation of so many features within the
TRa/Rev-erba locus in marsupials, it seemed likely that
marsupials might express an alternatively spliced mRNA
yielding a truncated version of TRa2. To characterize
expression of mRNAs from Rev-erba and TRa genes we
examined RNA from multiple tissues from M. domestica
at six different ages ranging from newborn animals
(0 days) to weanlings (9 weeks) and young adults
(18 weeks).
Expression of both TRa1 and Rev-erba mRNAs was
readily detected at all stages by RT-PCR. Since newborn
and one-week animals are only 10 mm and 16 mm in
length, respectively, these animals were simply divided
into two parts, heads and bodies, for extraction of RNA.
Beginning with two-week animals, six different tissues
were collected: cerebral cortex, cerebellum, liver, kidney,
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TCACTGTGCATCTACTCGGAAGGACAGCAGCTTCTCGGAATGCATGTTGTTGAGGGTGCGCAGGTCAGGCAGCTTAAGCAGCAGCTTGGTGAAGCGGGAGGT
TCACTGGCCATCTACTCGGAAGGACAGCAGCTTCTCGGAATGCATGTTGTTGAGGGTACGGAGGTCAGGCAGCTTAAGCAGTAGCTTGGTGAAGCGGGATGT
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Figure 2 Organization of sequence homologous to Exon 10 of TRa2. A. Overlap between terminal exons of TRa2 and Rev-erba mRNAs as
in Figure 1. Light vertical lines in Rev-erba coding sequence represent >30 synonymous substitutions within exon 8 of Rev-erba. Thin horizontal
arrows represent C-terminal polypeptides potentially or actually translated from exon 10 of TRa2. Dotted arrow indicates frame-shifted translation
product of potoroo and wallaby. Asterisk on longest arrow indicates position of phosphorylation sites on rat TRa2. Double brackets under figure
mark sequences highlighted in panels B and C. B. Alignment of 3’ss and 5’ end of exon 10. Nucleotide sequence from rat and four marsupials is
shown. The amino acid sequence corresponding to exon 10 of TRa2 is shown for the rat and the two opossums. Dashes indicate gaps and dots
residues identical to sequence above. Boxes indicate stop codons in-frame with the 3’ splice sites for either TRa2 (sense strand) or Rev-erba
(antisense strand). C. Alignment of overlapping coding sequences for TRa2 and Rev-erba. The amino acid sequence for the rat TRa2 sequence
(sense strand) is shown above the nucleotide sequence and the conserved amino acid sequence of Rev-erba is shown at the bottom. Stop
codons are indicated for Rev-erba (black box, repeated from panel B) and that hypothesized for TRa2 of wallaby and potoroo (white box)
assuming use of the homologous 3’ss splice site. The single amino acid substitution in the potoroo Rev-erba sequence is indicated in italics
(A/G). The stop codon for Rev-erba is shown boxed in both alignments.
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skeletal muscle and heart. For each tissue at each stage,
both TRa1 and Rev-erba expression were readily
detected by realtime RT-PCR and expression of both
mRNAs was confirmed by sequencing PCR amplification
products. Results of these assays are summarized in Fig-
ure 3A for heads and bodies of newborn (0 or 1 week),
and cerebral cortex and livers of older animals (2-18
weeks). Similar results are shown for four other tissues
in additional file 3. Increasing expression of Rev-erba
correlates strongly with increasing age (with a linear
correlation coefficient, r > 0.95 in skeletal muscle, kid-
ney, cerebellum and liver, and r> 0.74 in brain and
heart). The highest levels of Rev-erba expression were
observed in liver and skeletal muscle; the lowest levels
were in heart. In all tissues except liver Rev-erba
showed a large, 4- to 6-fold increase in expression
between 4 and 9 weeks (p < 0.001). In fact, TRa1
expression also showed a strong, if less pronounced,
correlation with increasing age in all tissues except heart
(r ≥ 0.95 for TRa1 in kidney and cerebellum and r ≥
0.74 in brain, muscle and liver) (additional file 3).
In contrast to TRa1 and Rev-erba mRNA expression,
both realtime and conventional RT-PCR assays for
TRa2 were consistently negative. To confirm this result,
multiple pairs of primers were tested, including forward
primers in exons 7, 8 and 9 and reverse primers anneal-
ing to different sites within the region homologous to
TRa2 exon 10 and Rev-erba exon 8. While the thresh-
old values obtained for TRa1 were highly reproducible,
typically varying by <0.2 cycles for a given set of repli-
cas, replica samples run with primers for TRa2 were
highly variable, either displaying large threshold values
or altogether failing to cross the threshold. Melt-curves
(not shown) and gel electrophoresis of these products
revealed a heterogeneous array of non-specific products,
as illustrated in the replica lanes shown in Figure 3D.
Additional file 4 summarizes threshold values from real-
time RT-PCR for TRa2 across all tissues and ages
(including the testes from 2 and 4 month animals) and
shows parallel values for TRa1 for comparison. Two dif-
ferent downstream primers for TRa2 were used for
most of these assays. In none of the assays was a pro-
duct obtained consistent with splicing of TRa2 mRNA
in opossum.
To test the efficiency and sensitivity of the TRa2 pri-
mers, realtime RT-PCR was carried out with a short
synthetic DNA template matching the predicted ampli-
con sequence of opossum TRa2 mRNA. Serial dilutions
of this template were assayed in the presence of a fixed
amount of a negative cDNA preparation of M. domes-
tica total RNA from cerebral cortex. The plot in Figure
3E indicates that these TRa2-specific primers have a
high efficiency, >99% [39], and a sensitivity at CT = 33
of less than 50 copies of TRa2 cDNA.
Expression of TRa and Rev-erba mRNAs was also
measured by RNase protection assays on total RNA
from the head (day 0 and week 1 animals) or cerebral
cortex (2-18 week animals) as shown in Figure 3B.
?
?
TR?1
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Rev-
erb?
?
Age ? ? ? ? ? ? ? ??
???????? ? ? ? ? ? ? ? ? ? ? ? ? ?
Head/Cerebral Cortex Body/Liver
?
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36 
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24
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???α   
Figure 3 Expression of TRa1, Rev-erba and TRa2 mRNAs in the
opossum Monodelphis domestica. A. Expression of TRa1 and Rev-
erba in staged animals is shown for heads and bodies (0 days and one
week of age, hatched bars) or cerebral cortex and liver (2-18 weeks,
evenly shaded bars) based on realtime RT-PCR analysis. Results are
averages from at least three animals with each assay performed in
triplicate. Brackets indicate standard deviations. B and C. RNase
protection assays of TRa (B) and Rev-erba (C) expression in heads (0
days and one week) or cerebral cortex (2-18 weeks). Probes extend
across exon 9A (TRa1) or the 5’ss of exon 6 (Rev-erba) as indicated in
Figure 1A, yielding protected bands of 156 or 137 nts for TRa1 or Rev-
erba, respectively. Control lanes include HEK 293 cell RNA which
contains a low level of endogenous human RNA that cross-reacts with
the opossum TRa probe (compare with a similar control with the
opossum probe in Fig. 4D). Arrows indicate positions of the expected
products. D. Electrophoretic analysis of realtime RT-PCR reactions
illustrating absence of TRa2 expression in M. domestica. Analysis of
reactions run on same cDNA sample (day 0 heads) with arrows
indicating positions of amplification products for TRa1 and Rev-erba
mRNAs and positions of product expected from correctly spliced TRa2
mRNA. Three replica reactions for TRa2 show a variety of artifactual
products but no detectable product of the expected size. E.
Amplification of a synthetic TRa2 template based on homologous
sequences from opossum. Threshold cycle values (CT) are shown for
serial dilution of test DNA in the presence of a constant amount of
cDNA from day 0 heads (which has no detectable TRa2). Efficiencies of
99.4% and 99.6% were calculated from two independent preparations
of the gel-purified synthetic template.
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From the specific activity of the probe, the level of
TRa1 mRNA was determined to vary between 0.3 and
0.7 amol/μg RNA (1 amol = 10-18 moles) with no clear
stage-specific trend. On the other hand, Rev-erba
increased steadily from less than 0.1 amol/μg RNA in
day 0 animals to about 1.0 amol/ug RNA in 18 week
animals (Figure 3C), a trend paralleling the increase
observed by realtime RT-PCR in cerebral cortex and
several other tissues (Figure 3A and additional file 3).
TRa1 expression was assayed with a probe that
extended across the 3’ and 5’ splice sites for exon 9A.
The length of the protected fragment for TRa1 reveals
efficient splicing of the former but not the latter site. In
older opossums (9 and 18 weeks) a faint band corre-
sponding in size to that expected for use of the 5’ss of
TRa2 was observed. The presence of this band raises
the possibility that an alternatively spliced product with
a similar 5’ss to TRa2 is expressed in older animals.
However, further efforts to identify such a product were
unsuccessful.
Requirements for splicing of TRa2
Although we found no evidence of TRa2 expression in
M. domestica, the possibility remained that its expres-
sion is tightly restricted to some tissue, developmental
stage or particular set of physiological conditions. To
examine the intrinsic competency for splicing of con-
served sequences corresponding to the 3’ss of exon 10
of TRa2, an opossum minigene was constructed based
on the structure of a rat minigene that efficiently
expressed TRa2 mRNA in transfection assays [32,40].
The construct consisted of exons 7-10 of TRa, extend-
ing downstream to exon 7 of Rev-erba, with all the
intron sequences except for a large deletion within
intron 9 that eliminated the competing TRa1 polyade-
nylation site and much of the preceding 3’ UTR (Figure
4A). This minigene was efficiently expressed in transient
transfection assays in HEK 293 cells. RNA processing
was assayed for both spliced (TRa2) and partially
spliced ("unspliced” TRa1-like) RNA by conventional
PCR (Figure 4B) and realtime RT-PCR (Figure 4C), as
well as RNase protection assays (Figure 4D). Bands cor-
responding to spliced TRa2 were evident for the rat
minigene (R-R) in all three assays. Real-time PCR and
RNase protection assays yielded quantitative measures
of TRa2 splicing relative to unspliced TRa1 of 64-77%,
consistent with earlier results for this minigene con-
struct. Conventional PCR employing larger amplicons
reveals a minor amount of a second spliced product cor-
responding to the minor spliced isoform, TRa3 (small
arrow, Figure 4B). In contrast, no spliced product could
be detected from the opossum minigene (O-O). The lar-
ger band evident in Figure 4B (lane O-O) corresponds
to readthrough sequence, while the heterogeneous
bands in Figure 4C represent non-specific amplification
products observed after 44 cycles of amplification. Close
examination of the RNase protection assays (Figure 4D)
revealed no bands corresponding to splicing of exon 9A.
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Figure 4 Splicing of chimeric TRa minigenes. A. Schematic
showing intron-exon structure of TRa minigene. Light shading
indicates the TRa2 3’UTR. Vertical brackets indicate a 3.2 kb deletion
in intron 9. Heavy horizontal line represents the exon 9A RNase
protection probe (panel D). Arrows represent primers used for PCR
(panels B and C) as described in Methods. Primer positions for TRa2
mRNA are indicated separately for rat (solid arrows) and opossum
(dashed arrows); those for TRa1 are located at nearly identical
positions. The composition of chimeric minigenes is indicated by
horizontal bars aligned with structure at top: dark and light shading
represents opossum and rat sequences, respectively. B, C.
Electrophoretic analysis of conventional (B) or realtime (C) RT-PCR of
RNA from transfected HEK 293 cells using primers indicated in Panel
A. Large arrows indicate PCR products from correctly spliced TRa1
or TRa2 mRNAs. Dotted arrows indicate spliced products obtained
from cryptic splicing within exon 10. Larger products seen with
TRa2 primers from R-O, O-O and O/RpA represent readthrough of
unspliced or partially spliced RNAs, low levels of contaminating DNA
(Panel B) or non-specific products (Panel C). ΔCT values shown in
Panel C represent differences observed between threshold cycles
(CT) for TRa1 and TRa2 (ΔCT = CT
TRa1 - CT
TRa2) averaged over three
replica assays from each of three independent experiments. D.
Analysis of minigene splicing by RNase protection assays using
probes for exon 9A. E. Summary of results in panels B, C and D. Plus
signs represent reactions where correct splicing of TRa2 was
detected following sequencing of conventional PCR products. %
splicing was calculated from ΔCT values (see Methods) with
standard deviations given in parentheses. Asterisks represent
possible false positives from non-specific RT-PCR products or high
background in RNase protection assays.
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Figure 4E summarizes the results of each of the assays.
A low level of residual background activity was routinely
detected with RNase protection assays and real-time
PCR yielding heterogenous amplification products, as
indicated by asterisks in Figure 4E.
Given the efficiency of TRa2 splicing in the rat con-
struct (R-R), the complete lack of expression of TRa2
splicing with the opossum minigene (O-O) was surpris-
ing. Both the 5’ and 3’ splice sites corresponding to
TRa2 are highly conserved in the rat and the opossum
(Figure 2B and additional file 2), as are intronic
sequences adjacent to 5’ and 3’ splice sites. Despite the
high conservation of these sequences in marsupials and
eutherians, the opossum TRa gene may lack cis-acting
elements required for TRa2 expression [32,38,40]. To
extend this analysis chimeric minigenes were con-
structed and assayed for their ability to express TRa2.
One construct, O-R, consisting of opossum exons 7-9
upstream of the rat TRa2 3’ splice site and exon10,
expressed TRa2 transcripts at levels similar to the rat
minigene (Figure 4B, C, and 4D). Sequencing of the RT-
PCR product obtained from transfected cells confirmed
that this product was accurately spliced from the homo-
logous 5’ splice site in exon 9 of opossum to exon 10 of
rat. In contrast, the reciprocal construct (R-O) with rat
sequences upstream (exons 7-9) and opossum sequences
downstream (exon 10) was apparently unable to express
spliced TRa2 mRNA. In all of the constructs tested, the
upstream exons 7, 8 and 9 are efficiently and accurately
spliced, but only in O-R, not O-O or R-O, is the down-
stream splice site corresponding to exon 10 efficiently
used. These results demonstrate that sequences homolo-
gous to the TRa2 5’ splice site in exon 9 of opossum
are fully competent for splicing, while those homologous
to the TRa2 3’ss in exon 10 are not.
To more precisely define cis-acting elements required
for TRa2 splicing, two additional minigenes were tested.
The first of these, designated O/Rx10, was constructed
from the O-R chimera by replacing the rat sequence
upstream of the TRa2 3’ splice site but downstream of
intron 9 deletion with the opossum sequence present in
the O-O minigene. The other chimeric minigene, O/
RpA, was constructed by incorporating opossum
sequences into the length of exon 8, thus eliminating
the rat 3’ss for TRa2 while retaining the rat TRa2 poly-
adenylation site (Figure 4A). When these chimeric mini-
genes were transfected into HEK 293 cells the efficiency
of TRa2 splicing was greatly reduced or eliminated.
Careful analysis revealed that the O/Rx10 minigene
expressed a small amount of correctly spliced chimeric
TRa2 mRNA, as indicated by both RPA and RT-PCR
assays, but with greatly reduced efficiency, strongly sug-
gesting that opossum sequences in the intron upstream
of exon 10 are incompatible with TRa2 splicing.
Post-run analysis of both R-O and O/RpA real-time
products yielded a weak band in the region expected for
correctly spliced product as indicated by the asterisks in
Figure 4C. However, the difference between TRa1 and
TRa2 CT values (ΔCT in Figure 4C) was comparable or
less than that observed for the O-O minigene. Correct
splicing of these transcripts could not be confirmed by
other assays. Cryptic splicing within the opossum
sequence in O/RpA, 60 nt from the chimeric junction of
opossum and rat sequence, was detected by sequencing
a band obtained by conventional PCR. Conventional
PCR also demonstrated that R-R, O-R and O/Rx10 all
express a small amount of spliced TRa3, a minor var-
iant of TRa2 that uses an alternative 3’ss 117 bp down-
stream of the TRa2 3’ss in exon 10 [41]. For R-R and
O-R this represents a minor product, slightly smaller
than that for TRa2. For O/Rx10, however, this band is
proportionately more intense, indicating a loss of speci-
ficity as well as a greatly reduced efficiency of TRa2
splicing for the O-Rx10 minigene.
The analysis described above strongly suggests that
opossum sequences upstream of the 3’ss are incompati-
ble with TRa2 splicing. The discrepancy between TRa2
splicing of O-R and O/Rx10 indicates that the TRa
gene of M. domestica lacks upstream cis-acting elements
required for efficient splicing of TRa2. Furthermore,
inclusion of the rat TRa2 polyadenylation site, which is
not conserved in marsupial species (additional file 2), is
insufficient to restore accurate and efficient splicing in
chimeric constructs O/Rx10 and O/RpA.
Expression of endogenous and transfected mRNAs in
PtK1 cells
Analysis of the splicing of chimeric minigenes demon-
strates that the opossum sequences homologous to the
3’ss of TRa2 splicing are not used efficiently. This most
likely reflects the lack of cis-acting elements in opossum
that are necessary for TRa2 expression [38,40]. It is pos-
sible, however, that the failure of opossum tissues to
express TRa2 reflects the presence or absence of a fac-
tor that specifically affects TRa2 processing. To test this
possibility we examined the processing of the rat TRa
minigene in potoroo PtK1 cells. These cells, derived
from kidney epithelium, endogenously expressed both
TRa1 and Rev-erba, but not TRa2 (Figure 5A). PtK1
cells were then transfected with three previously charac-
terized full-length rat minigenes [32]: a wildtype mini-
gene extending uninterrupted from exon 7 through
exon 10 of TRa2 (and further downstream to exon 2 of
Rev-erba); a mutant with a single base replacement at
the 5’ss of exon 9A (+5C/G), which overexpresses TRa2
mRNA; and a second mutant at that 5’ss with substitu-
tion at the adjacent site (+6T/G), which results in a
decrease in TRa2 mRNA. When transfected into PtK1
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cells, each of these constructs expressed TRa1 and
TRa2 mRNAs at levels expected from previous expres-
sion studies in rodent and human cells (Figure 5B) [32].
These results demonstrate that marsupial cells expres-
sing only endogenous TRa1 are fully capable of splicing
rat TRa2.
Discussion
Results of these studies show that TRa1 and Rev-erba
mRNAs are widely expressed in opossum in a manner
similar to that in rodents, where both receptors are
readily detectable in most tissues throughout develop-
ment [20,42,43], with expression peaking in post-natal,
pre-weanling mice and rat. Since marsupials are born at
a relatively early stage of development and mature more
slowly than rats and mice, the ages used here corre-
spond roughly to late pre-natal through post-weanling
stages in rats. The striking increase in the expression of
Rev-erba in most tissues with increasing age is also con-
sistent with that reported for rat [44]. However, the
failure to detect expression of TRa2 in a broad range of
tissues at ages ranging from day 0 newborns to
4 month-old young adults contrasts strongly with the
co-expression of all three of these mRNAs from this
locus in rats, mice and other mammals.
The expression of any one of these mRNAs, TRa1,
TRa2 or Rev-erba, is almost always accompanied by
expression of the other two, although the relative ratios
vary widely [20,21,33]. Our analysis focused on the
expression of these receptors in the central nervous sys-
tem, as TRa2 mRNA is expressed at much higher levels
than TRa1 in both cerebral cortex and cerebellum
[42,43]. For example, in newborn rat brain TRa2 mRNA
is more than 30-fold more abundant than TRa1 [42].
Furthermore, TRa2 expression in rats is several fold
greater than TRa1 expression in brain, liver and kidney
at all ages examined (day 15 embryos to adult) [42], a
striking contrast to the total absence of TRa2 mRNA
observed here in opossum and PtK1 cells.
Conservation of sequences in TRa and Rev-erba
The conservation of sequence spanning the 3’ ends of
TRa1 and Rev-erba has several features of interest with
respect to the evolution of TRa2 and the antisense over-
lap with Rev-erba. The amino acid sequence encoded by
the 3’ exon of Rev-erba is nearly identical in marsupial
and eutherian mammals (100% identity in rat and opos-
sum), suggesting that the coding sequence of Rev-erba
accommodated the evolution of its antisense overlap
with TRa2 within its functional constraints as the cod-
ing sequence for TRa2 threaded through 67 (antisense)
codons of Rev-erba and into the final intron of the Rev-
erba gene. Interestingly, the one specific function
ascribed to the unique C-terminal sequence of TRa2,
that associated with phosphorylation of certain serine
residues [45,46], maps to positions in TRa2 that are
encoded antisense to the final intron of Rev-erba and
are therefore not constrained by requirements for Rev-
erba coding as shown in Figure 2A.
The region in which the 3’ ends of TRa1 and Rev-
erba mRNAs converge is framed by exceptionally con-
served sequences within the 3’UTR of each mRNA
(additional file 2 ), suggesting the presence of numerous
functional elements important for the expression and
regulation of both nuclear receptor proteins. The appar-
ent conservation of core splice site elements important
for TRa2 expression is puzzling, given the apparent
absence of TRa2 mRNA in marsupials, and raises the
question of whether these elements correspond to TRa2
or have other functions. In particular, several features
are consistent with conservation of the alternatively
spliced TRa2-specific exon in marsupials: (1) conserva-
tion of the non-canonical AAG trinucleotide identical to
that found in all known eutherian genomes at the 3’ end
Figure 5 Expression of TRa and Rev-erba in potoroo PtK1 cells.
A. Endogenous expression of TRa1, TRa2 and Rev-erba mRNAs was
assayed by realtime RT-PCR (left; average of 3 replicas) and
conventional PCR (right). Expression of TRa1 and Rev-erba mRNAs
in the opossum, M. domestica (day 0 heads), was measured in a
parallel by realtime RT-PCR for comparison. Arrows on photograph
at right indicate positions of expected amplification products for
each mRNA. Two different primer pairs were targeted against TRa2,
which was not observed. The predicted products for TRa1 and Rev-
erba mRNAs were confirmed by sequencing. The Rev-erba RT-PCR
matches sequence obtained from PtK1 cell DNA (additional file 2).
No TRa2 mRNA was observed either by realtime RT-PCR or two sets
of primers located in exon 7 or 8 and exon 10. B. TRa2 splicing of
rat minigenes in PtK1 cells. Rat minigenes with full-length versions
of exons 7-10 were expressed inPtK1 cells and assayed by realtime
RT-PCR. Two previously characterized single-base point mutations in
the 5’ss of exon 9A [32] were analyzed in parallel with wild-type
and found to significantly overexpress (+5G) or underexpress (+6G)
spliced TRa2 in comparison with wildtype (p < 0.05).
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of exon 9 for TRa2; (2) the conservation of adjacent
sequences corresponding to the 5’ end of exon 10; and
(3) the conservation of the polypyrimidine tract that is
an essential feature of the core sequence of the 3’ss. In
fact, the marsupial polypyrimidine tract appears a better
match to the mammalian consensus sequence than that
found in rat: a G at position -6 is replaced with T in all
four marsupials and a somewhat higher proportion of
T/C residues is present in the marsupial polypyrimidine
tracts [47,48].
However, other features of this region are consistent
with the absence of TRa2 in opossum: (1) the open
reading frame corresponding to the extended C-termi-
nus of TRa2 is not conserved in four marsupials except
for the first 11 codons of TRa2 exon 10 in the opos-
sums; (2) the bidirectional coding overlap with Rev-erba
present in all eutherian species is eliminated in both
opossums; (3) the TRa2 ORF is disrupted in wallaby
and potoroo by a frame-shift deletion adjacent to the
presumptive splice site; (4) a conserved polyadenylation
signal corresponding to exon 10 of TRa2 is absent, and
there is overall poor conservation of sequence within
the final intron of Rev-erba (additional file 2); and (5)
there is poor conservation of intronic and exonic spli-
cing enhancer sequences required for TRa2 splicing
[38,40]. These include the SEa2 enhancer downstream
of the coding sequence for TRa1 [40], an intronic spli-
cing enhancer near the 3’ splice site of exon 10 and a
exonic enhancer located within the bidirectional coding
sequence of exon 10 [38]. Taken together, these differ-
ences suggest that the conservation of the elements
associated with TRa2 mRNA processing may reflect
other functional requirements at this locus unrelated to
TRa2 expression.
Splicing of TRa2 mRNA in chimeric minigenes
Analysis of splicing of opossum and rat minigenes cor-
roborated our finding that alternatively spliced TRa2
mRNA is missing in marsupials. Most telling was the O/
Rx10 construct, which includes the entire length of rat
exon 10, identical to that in O-R, except for replacement
of 180 bp of rat sequence upstream of the TRa2 3’ss
with 220 bp of opossum sequence. The longer opossum
sequence closely corresponds to a previously tested con-
struct (ErbAΔXP) which was spliced as efficiently as the
shorter sequence [38]. The overall level of splicing of O/
Rx10 was <10% that of O-R and the predominant
spliced product corresponded to TRa3, a minor splice
variant isoform, not TRa2, as shown by sequencing of
RT-PCR products (Figure 4B). These experiments
demonstrate that opossum sequences homologous to
the TRa2-specific 3’ss are almost completely inactive in
splicing transfected minigenes. In addition to the role of
these intronic sequences in blocking TRa2 splicing, the
opossum sequences also lacked a conserved polyadeny-
lation signal hexanucleotide (CATAAA) that is con-
served in all known TRa2 mRNAs. However, the
inclusion of this element (together with much additional
rat sequence) in the O/Rx10 and O/RpA minigenes was
not sufficient to rescue efficient splicing.
Evolution of TRa2 mRNA in mammals
A number of studies suggest that the evolution of new
alternative exons provides an important pathway for the
creation of novel proteins and regulatory pathways in
eukaryotic cells [49-52], reviewed in [53]. Given the pro-
minence of TRa2 as an abundant isoform in eutherian
mammals [42], its proposed role as a dominant negative
modulator of thyroid hormone activity [19] and the pos-
sible regulatory implications of its overlap with Rev-erba
[33], the evolution and function of TRa2 in mammals
are of particular interest.
Three distinct evolutionary scenarios or models may
account for similarities and differences of this locus in
marsupial species as summarized in Figure 6. The first
scenario, in which TRa2 expression is restricted to the
eutherian lineage, suggests that some features of the
marsupial TRa/Rev-erba locus are intermediate between
those of eutherian mammals and non-mammalian verte-
brates. For example, the poly(A) sites of TRa1 and Rev-
erba are nearly identically spaced in rat and opossum
and much closer than in the amphibian Xenopus tropi-
calis, where they are more than 10 kb apart [38]. On
the other hand, marsupials, like non-mammalian verte-
brates, appear to lack an authentic TRa2 isoform. Also,
the amino acid sequence of the marsupial TRa1 (addi-
tional file 1 Panel A) shows striking similarities to that
of chicken. The opossum TRa1 amino acid sequence
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Figure 6 Models for the evolution of antisense exon 10 in TRa
and expression of the TRa2 isoform. Three models are proposed
for the evolution of the TRa2 isoform and its antisense overlap with
Rev-erba. In the first model (TRa2 “late”), alternatively spliced TRa2
mRNA evolved only after the divergence of marsupial and eutherian
mammals so that TRa2 is unique to eutherian mammals. In the
second model (TRa2 “early”), a functional but primitive version of
TRa2 (uTRa2) evolved early in the course of mammalian evolution,
but in marsupials the modern, truncated form of TRa2 (tTRa2) is
expressed only at very low levels or its expression is temporally or
spatially restricted. In the third model (TRa2 “lost”), a functional
version of TRa2 (uTRa2) evolved very early in the common ancestor
of marsupial and eutherian mammals, but this alternative isoform
was lost at some later time in marsupial lineage.
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differs from chicken in only 22 positions as compared to
25 positions in rat (additional file 1 Panel A), despite a
slightly greater similarity between the opossum and rat
nucleotide coding sequences. In 20 of the 25 positions
where opossum and rat TRa1 differ, the opossum
sequence is identical to that of chicken. Most of these
sites are also conserved in frog, a more distantly related
vertebrate (result not shown). These observations suggest
that the marsupial TRa locus has retained several charac-
teristics reminiscent of non-mammalian vertebrates.
The second scenario, in which a truncated form of
TRa2 is expressed in some limited (though as yet unde-
tected) fashion, also suggests that the marsupial locus
may represent a stage intermediate between the more
complex eutherian locus, with its extended antisense
overlap with Rev-erba and abundant expression of
TRa2, and the non-mammalian vertebrates, which
entirely lack TRa2. Support for this model is found in
the fact that many features characteristic of the marsu-
pial TRa/Rev-erba locus are associated with the crea-
tion of novel alternatively spliced exons, according to
several recent studies [49-53]. These include inefficient
splicing coupled with restricted or low levels of expres-
sion, as posited in the second model, and the absence of
an extended open reading frame.
The third scenario, that TRa2 evolved early but was
lost in the marsupial lineage, suggests that features char-
acteristic of TRa2 that are shared by marsupial and
eutherian mammals are vestiges of this loss. These vesti-
gial features may have acquired other secondary func-
tions within this locus. Although this scenario may
appear overly complex and hence unlikely, careful analy-
sis of nuclear receptor evolution throughout multiple
metazoan phyla reveals that loss within a particular line-
age is not at all uncommon [54]. Among approximately
25 nuclear receptor proteins that appear to have been
present in the last common ancestor of vertebrate and
bilaterian invertebrate species, a number of nuclear
receptors, including both thyroid hormone receptor
genes, are missing entirely from major groups of animals
such as nematodes or arthropods while specific ortho-
logs for both thyroid hormone receptors and Rev-erb
are found in more distantly related animals, such as
mollusks, tunicates and flatworms [55-57].
Although none of the three models can be definitively
ruled out, on balance, the first scenario might be judged
most likely. The failure to detect TRa2 expression in
tissues and stages where it is abundantly expressed in
eutherians, the poor efficiency of TRa2 minigene spli-
cing, the absence of a discernible TRa2 polyadenylation
signal element and differences between the presumptive
coding sequence for TRa2 in two marsupial orders
weigh against the second model. The differences and
similarities among the marsupial sequences within the 3’
UTR of Rev-erba (Figure 2 and additional file 2),
including strict conservation of 3’ processing sites for
TRa1 and Rev-erba, seem most consistent with the first
model, in which sequence conservation reflects regula-
tory requirements for these convergent mRNAs rather
than vestiges of a once functional, alternatively spliced
mRNA, as suggested in the third model.
If the first scenario is correct, apparent similarities
between marsupials and eutherians in the region corre-
sponding to the TRa2 3’ ss and exon 10 must reflect
other conserved functions. The first model thus suggests
core elements of the TRa2 splice site were coopted (or
“exapted”) [58,59] during the evolution of TRa2. What,
then, are the possible functions of these sequences? It is
likely that they reflect the overlay of elements involved
in regulating expression of TRa and Rev-erba, as well
as other possible roles. Accumulating evidence suggests
that sequences at the 3’ ends of genes play multiple
roles in regulating gene expression. These include target
sites for microRNA binding [60], sites for binding of
proteins regulating transcription termination, 3’ end
processing, turnover and translation [61,62], and promo-
ters for expression of non-coding transcripts that are
often found within the 3’ UTRs of transcripts [1,3,7].
Physiological correlates of nuclear receptor function
The physiological role of TRa2 has remained elusive
since its discovery more than two decades ago, despite
numerous genetic and molecular investigations of its
function [63-65]. Although many studies have focused
on its role as a weak dominant negative competitor of
TRa1 or TRb isoforms [19,66-68], other studies have
pointed to its phosphorylation-dependent RNA-binding
activity and cytoplasmic localization [46,69,70]. These
properties, along with the developmental regulation of
its expression, suggest a role for TRa2 in developmental
regulation of T3 activity [71,72]. The present study
strongly indicates that its function is specific to the
eutherian lineage, and thus may ultimately be resolved
by comparative analysis of relevant aspects of marsupial
and eutherian physiology.
The multiple roles ascribed to Rev-erba and TRa1 in
metabolic, circadian and developmental signaling
[22,27,73-75] require a diversity of regulatory inputs
that determine the expression and physiological activity
of these receptors [20,21]. The evolution of the antisense
overlap between TRa2 and Rev-erba mRNAs in euther-
ian mammals is likely to be associated with additional
mechanisms that affect the expression or activity of
both receptors.
Conclusions
Analysis of the TRa/Rev-erba locus in four marsupial
species strongly suggests that the alternatively spliced
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TRa2 isoform, which is widely and abundantly
expressed in all known eutherian mammals, is not pre-
sent in marsupials. Three observations support this con-
clusion: first, we can find no evidence for TRa2
expression in any of multiple tissues or developmental
stages surveyed; second, the coding sequence specific to
TRa2 is severely truncated in opossums and completely
altered in the wallaby and potoroo; and third, opossum
sequences homologous to the 3’ss specific for TRa2 are
utilized very inefficiently for splicing of chimeric mini-
genes. The antisense overlap between TRa2 and Rev-
erba mRNAs, which is tightly conserved in eutherian
mammals, appears to have evolved within the con-
straints of the conserved C-terminal coding sequence of
Rev-erba. These results suggest that comparative analy-
sis of these genes in marsupials and eutherian mammals
will provide further insight into the evolution, function
and expression of TRa2 and the regulatory implications
of its antisense overlap with Rev-erba.
Methods
Tissues and cells
Monodelphis domestica tissues were harvested from
staged animals obtained from stocks maintained at the
Southwest Foundation for Biomedical Research. The
opossums were maintained under standard conditions
for this species [76]. The Southwest Foundation for Bio-
medical Research is accredited by the Association for
the Assessment and Accreditation of Animal Care,
International. All procedures were approved by the
Institutional Animal Care and Use Committee and con-
formed to the Public Health Service Policy on Humane
Care and Use of Laboratory Animals. DNA was col-
lected from animals at birth (0 days), 1, 2 and 4 weeks,
2 months (9 weeks) and 4 months (18 weeks). DNA
from Didelphis virginiana was isolated from a purchased
sample of brain tissue (Pel-Freez; Rogers, AR). Potorous
tridactylus PtK1cells (CRL-6493) were obtained from
ATCC (Manassas, VA) and passaged in Dulbeccos mod-
ified Eagles medium with 10% fetal bovine serum.
Nucleic acid sequencing and cloning
DNA was sequenced from the overlap regions spanning
the TRa and Rev-erba genes of Didelphis virginiana and
Potorous tridactylus following amplification of total DNA
using primers complementary to conserved sites within
exon 9 of TRa1 and exons 7 and 8 of Rev-erba. mRNA
sequencing was similarly carried out with cDNA obtained
by randomly primed reverse transcription of total RNA
(Superscript II; Invitrogen) following homogenization of
tissue in TRIzol according to manufacturer’s instructions
(Invitrogen). Amplified genomic products were also
cloned into pGEM-T vector (Promega; Madison, WI)
and subcloned into pErbA construct as previously
described [40]. PCR amplifications were carried out with
Taq polymerase (Promega). All primers were from Inte-
grated DNA Technologies (Coral, IA)
Minigene plasmid constructs are based on the rat con-
struct, pErbAΔXE (R-R in Figure 4). Both the rat and
possum constructs include all but the first 20 bp of
exon 7, and all of exons 8, 9A and 10 [32,38]. In this
plasmid intron 9 sequences are deleted from an XbaI
site 490 bp downstream of the 5’end of exon 9 in rat
and a site 186 bp upstream of the exon 10 3’ss.
Sequences of both rat and opossum minigenes extend to
a unique BstEII site in Rev-erba exon 7 that is con-
served in M. domestica. The opossum minigene, pErbA
(O-O) ("O-O” in Figure 4) includes 620 bp of intron 9
upstream of the deletion and 226 nts downstream fol-
lowing insertion of an XbaI site to facilitate swapping of
rat and opossum sequences in construction of the chi-
meric plasmids pErbA(O-R) and pErbA(R-O) (Figure
4A). Chimeric plasmids pErbA(O/RpA) and pErbA(O/
Rx10) were prepared by two-step recombinant PCR as
previously described [38]. Wild-type plasmid pCMV-
ErbAm and the corresponding 5’ss point mutants, +5C/
G and +6T/G, have been previously described [32].
The following DNA and mRNA sequences (with NCBI
accession) were analyzed using Vector NTI software
(Invitrogen): M. domestica NW_001581875.1,
XM_001370259, XM_001362861; Ratus novegicus
NW_047339, NM_001017960, NM_031134, NM_001
113422; Gallus gallus NM_205313. The Macropus euge-
nii genomic sequence was assembled from the following
files in the trace archives: ti:1070151041, ti:1437108730,
ti:1378054157, ti:1582562684, ti:1623537866, ti:148431
7168, ti:1467742023, ti:1070151372.
The following sequences have been deposited in the
GenBank: M. domestica TRa1 mRNA (HM149330),
P. tridactylus TRa1 (HM149329), P. tridactylus NR1D1
(HM149328), P. tridactylus TRa1/Rev-erba genomic
sequence (HM149331), D. virginiana TRa1/Rev-erba
genomic sequence (HM149332). The M. eugenii TRa1/
Rev-erba genomic sequence has been deposited in the
NCBI Bankit database (BK007078).
Transfection assays and RNA analysis
Plasmids were transfected into HEK 293 cells using cal-
cium phosphate as described [32] and into PtK1 cells
with Lipofectamine 2000 (Invitrogen). Total RNA was
prepared from transfected cells with TRIzol 48 h post-
transfection. RNA was assayed by RNase protection
assays as previously described [32,33]. Riboprobes for
rat TRa1/TRa2 exon 9 and Rev-erba exon 5 have been
previously described [32]. Similar riboprobes were pre-
pared for opossum Rev-erba exon 5, TRa1 exons 9A,
and TRa1 poly(A) site by in vitro transcription of PCR
products cloned into pGEM-T vector (Promega) using
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primers described in (additional file 5). The riboprobe
for opossum, unlike that for rat, extended upstream into
intron 8 as well as downstream of the site homologous
to exon 9A in TRa2 (Figure 4A). 3’RACE was carried
out on RNA from liver and cerebral cortex from
4 month animals using gene specific primers for opos-
sum Rev-erba. Direct sequencing of PCR products
obtained with two gene-specific primers confirmed the
presence of a major poly(A) site coincident with that
found in rat, human and mouse in the EST database.
Quantitative realtime RT-PCR was carried out as fol-
lows. Total RNA was randomly primed and reverse
transcribed with Superscript II. For expression assays
with possum tissues, 4 ug of total RNA was used per
reaction and the equivalent of 0.1 μg of RNA product
was used in a 25 μl reaction containing Bio-Rad Sybr-
Green Supermix and 150 nM primers (additional file 5
). RNA from transfected cells was similarly treated
except less RNA was used. PCR values from opossum
tissues were normalized to expression of opossum b-
actin with primer to exons 5 and 6. Realtime PCR assays
were carried out on a MyiQ Realtime Thermocycler
using IQ SyberGreen Supermix and analyzed according
to the manufacturer’s instructions (Bio-Rad Labora-
tories; Hercules, CA).
The following primers were used for amplification of
chimeric gene products as shown in Figure 4C, with
expected amplicon lengths (in base pairs) given in par-
entheses: for TRa1 in O-O, O-R, O/Rx10 and O/RpA: 1F/
2R (290); for TRa1 in R-R and R-O: 15F/16R (291); (2) for
TRa2 in O-O and O/RpA 1F/6R (271); for TRa2 in O-R
and O/Rx10 1F/17R (222); for TRa2 in R-O 15F/6R (251);
and for TRa2 in R-R 15F/17R (202). For conventional
PCR shown in Figure 4B (40 cycles) the same primers for
TRa1 but for TRa2 longer amplicons were used: O-O and
O/RpA 20F/21R (722); O-R and O/Rx10 20F/23R (728);
R-R 22F/23R (471); and R-O 22F/21R (464).
The efficiency of TRa2 primers was determined from
the slope of the semilogarithmic plot of template con-
centration vs. CT using the equation, efficiency = [10^
(-1/slope)] -1 [39]. As a further test of primers used to
probe for TRa2 expression, the “forward” TRa2 primer
was paired with a “reverse” primer specific for TRa1,
while the “reverse” TRa2 primers were paired with a
“forward” primer specific to the 3’ UTR of Rev-erba.
Each of these primer combinations efficiently amplified
the expected mRNAs, supporting the conclusion that
the failure to detect TRa2 mRNA does not reflect short-
comings of primer design (data not shown). Relative
expression of TRa1 and TRa2 and percent splicing of
TRa2 were calculated from realtime RT-PCR assuming
100% amplification efficiency. The significance of
changes in expression was evaluated by Student’s two-
sample unpooled t test.
Additional material
Additional file 1: Alignment of TRa1 mRNAs for R. norvegicus, M.
domestica, P. tridactylus and G. gallus. A. TRa1 mRNA. The amino acid
sequence for Gallus gallus (chick) TRa1 is included below that for R.
novegicus (rat), M. domestica (SAO) and P. tridactylus (potoroo). B. Rev-
erba mRNA. Start and stop codons are boxed in red as is the 5’ splice
site for TRa2 in exon 9 of TRa1 in panel A. The boundary between
exons 8 and 9 is indicated in panel B with a vertical line.
Additional file 2: Alignment of genomic sequence showing overlap
region for rat, M. domestica (SAO), D. virginiana (NAO), P. tridactylus
(potoroo) and M. eugenii (wallaby). The alignment is annotated to
show various features including polyadenylation sites and splice sites.
The boundaries for subregions indicated in Figure 1B are also shown
(vertical lines):. Red boxes indicate in-frame stop codons and
polyadenylation signal sequences. Dotted red boxes in marsupial
sequences show those stop codons inframe with the TRa2-specific splice
site (as in Figure 2). Red arrows mark splice sites and polyadenylation
sites.
Additional file 3: Expression of TRa1 and Rev-erba in cerebellum,
kidney, skeletal muscle and heart expression isolated from 2 to 18
week old opossums. Tissues from 2, 4 9 and 18 week old opossums (M.
domestica) were assayed for TRa1 and Rev-erba expression as in Figure
3A. Results are averages of three animals, with each assay performed in
triplicate. Brackets indicate standard deviations.
Additional file 4: Table showing realtime RT-PCR data illustrating
absence of detectable TRa2 mRNA in opossum tissues. Uncorrected
threshold values (CT values) are shown for TRa2 mRNA in upper left of
the box for each age and tissue. For comparison, values for TRa1 in
parallel runs are shown the lower right of each box. Each value is the
average of 3 replica determinations from a single run, with samples
failing to reach the threshold arbitrarily set to 42 in determining the
average. Boxes outlined in bold show runs where measurements for
TRa1 and TRa2 were carried out simultaneously. All samples were
assayed for TRa2 with two different primer sets. Values shown without
asterisks were measured with the primer pair evaluated in Figure 3E.
Asterisks indicate measurements with an alternate TRa2 primer pair also
used in Figure 3D. Replica values for TRa1 show little variation (SD< 0.2
for all but 4 measurements). CT values for TRa2 typically showed high
values ( > 38) and/or substantial variation (SD > 1) characteristic of non-
specific products over a 44 cycle run.
Additional file 5: Table of primers used for PCR, DNA sequencing
and plasmid constructions.
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